The PRWIRE Press Releases http:// 2017-03-28T12:13:05Z Cryocooler Market worth 2.94 Billion USD by 2022 2017-03-28T12:13:05Z cryocooler-market-worth-2-94-billion-usd-by-2022 The report "Cryocooler Market by Type (GM, PT, JT, Stirling, and Brayton Cryocoolers), Service (Technical Support, Product Repairs & Refurbishment, Preventive Maintenance, and Customer Training), Application, and Geography - Global Forecast to 2022", The global cryocooler market is expected to grow to USD 2.94 Billion by 2022, at a CAGR of 7.29% between 2016 and 2022. The major factors driving the growth of this market include the shortage of helium gas, growing medical & healthcare services in the developing economies.Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=247727537 Browse 70 market data Tables and 94 Figures spread through 159 Pages and in-depth TOC on "Cryocooler Market - Global Forecast to 2022"http://www.marketsandmarkets.com/Market-Reports/cryocooler-market-247727537.htmlEarly buyers will receive 10% customization on this report. The military application in the cryocooler market held the largest share in 2015 The cryocooler market is application driven. This market has been segmented on the basis of application into military, medical, commercial, environmental, energy, transport, research & development, space, agriculture & biology, and others. The cryocooler market for the military application accounted for the largest share in 2015. This market is expected to grow at a significant rate between 2016 and 2022, driven by growing adoption of various cryocoolers to provide cryogenic temperatures for IR sensors in missile guidance, night vison based systems, and satellite based surveillance. The market for GM cryocoolers is expected to grow rapidly during the forecast period The cryocooler market based on type is segmented into GM, PT, Stirling, JT, and Brayton cryocoolers. Among these cryocoolers, the market for GM cryocoolers is expected to witness the highest growth during the forecast period. The major reasons for the growth of this market include wide adoption of GM cryocoolers for cooling IR sensors in medical MRI systems, cryosurgeries, and cryopumps in semiconductor applications. Also, the increasing number of GM cryocooler product launches catering to diverse industry segments is further contributing to the growth of this market. The cryocooler market in North America is expected to hold the largest share of the global cryocooler market by 2022 The cryocooler market in North America held the largest share of the global cryocooler market in 2015, followed by the markets in Europe and APAC. The market in North America is expected to grow at the highest rate between 2016 and 2022. This growth can be attributed to the shortage of helium gas and growing importance for cryocoolers in proton therapy to treat cancer and high adoption of cryocoolers in missile guidance and satellite monitoring in military application. The major players in the cryocooler market are Advanced Research Systems, Inc. (U.S.), Brooks Automation, Inc. (U.S.), Chart Industries, Inc. (U.S.), Cryomech, Inc. (U.S.), DH Industries BV (The Netherlands), Janis Research Company, LLC (U.S.), RICOR – Cryogenic & Vacuum Systems (Israel), Sumitomo Heavy Industries Ltd. (Japan), Sunpower, Inc. (U.S.), and Superconductor Technologies, Inc. (U.S.) among others. The scope of the report covers detailed information regarding the major factors influencing the growth of the cryocooler market such as drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been done to provide insights into their business overview, products and services, key strategies, new product launches, mergers & acquisitions, partnerships, agreements, collaborations, and recent developments associated with the markets. About MarketsandMarkets MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact:Mr. RohanMarkets and Markets UNIT no 802, Tower no. 7, SEZMagarpatta city, HadapsarPune, Maharashtra 411013, India1-888-600-6441Email: sales@marketsandmarkets.com Global Clinical Data Analytics Market is Projected to Grow at CAGR Of 41.50% During The Forecast Period of 2017 – 2022 2017-03-28T08:33:54Z global-clinical-data-analytics-market-is-projected-to-grow-at-cagr-of-41-50-during-the-forecast-period-of-2017-2022 ​The Global Clinical Data Analytics Market is valued at USD 2.25 billion in 2016 and is expected to reach a value of USD 24.03 billion by the end of 2022, growing at a Projected CAGR Of 41.50% During The Forecast Period of 2017 – 2022. Big data in healthcare is overwhelming not only because of its volume but also because of the diversity of data types and the speed at which it must be managed. The totality of data related to patient healthcare and well-being make up œbig data in the healthcare industry. By discovering associations and understanding patterns and trends within this data, big data analytics can help in improving care, save lives, and lower costs. Download PDF Clinical Data AnalyticsMarket@ http://www.orbisresearch.com/contacts/request-sample/215446 North America will be the biggest market for these solutions with a share of 55%, followed by Europe, Asia-Pacific and rest of the world. Clinical data analytics help physicians to take decisions about the patient's care or aid in better understanding of the health of their covered populations. The technology can vary according to the data involved or the users of the information or the actions which are at the discretion of decision makers who can be anyone like nurses, doctors, public health officials and senior management, etc. Browse Full Report with TOC: http://www.orbisresearch.com/reports/index/global-clinical-data-analytics-market-by-model-cloud-on-premise-services-consulting-maintenance-industry-geography-trends-forecast-2017-2022- The report focuses on different industry policies and factors which are driving the market growth. The report also provides key insights into strategies, market shares and solutions of key vendors like IBM, Caradigm, CareEvolution, Cerner, Explorys, InterSystems, McKesson, Wellcentive, athenahealth and Truven Health Analytics. Some of the major vendors who are providing stiff competition to existing players mentioned in the report are ActiveHealth Management, The Advisory Board Company, Humedica Inc., Comprehend Systems and Forte Research Systems. Place Purchase Order for this Report@ http://www.orbisresearch.com/contact/purchase/215446 DRIVERS Increasing focus of the population towards health management Supportive government policies Cost benefits The opportunity to provide better quality services to the patients RESTRAINTS Fragmented end-user market Software related privacy Security issues are some of the challenges of the clinical data analytics market WHAT THE REPORT OFFERS Market definition for the clinical data analytics market along with identification of key drivers and restraints for the market. Market analysis for the clinical data analytics market, with region-specific assessments and competition analysis on a global and regional scale. Identification of factors responsible for changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale. Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share. Identification and analysis of the macro and micro factors that affect the clinical data analytics market on both global and regional scale. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information." Table of Contents 1. Introduction 2. Current Market Trends 3. Market Overview 4. Market Insights Shares, Forecasts and Trends 5. Clinical Data Analytics Vendor Profiles 6. The Challengers 7. Competitive Landscape 8. The Future of Clinical Data Analytics Market" About Us: Orbis Research is a single point aid for all your Market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required Market research study for our clients. Contact Us:​Hector Costello Senior Manager – Client Engagements4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817; +912064101019 Email ID: sales@orbisresearch.com Australian company chosen to help re-build Mosul’s healthcare system as part of the global humanitarian effort in Iraq 2017-03-27T22:19:54Z australian-company-chosen-to-help-re-build-mosul-s-healthcare-system-as-part-of-the-global-humanitarian-effort-in-iraq Canberra-based Aspen Medical has been contracted by the World Health Organization (WHO) to provide healthcare professionals and hospital management at a 48-bed field hospital south of Mosul in northern Iraq.  The field hospital was established by WHO at the urgent request of the Ministry of Health in Iraq.  WHO is coordinating a number of organisations providing trauma care in the conflict zone. Aspen Medical will initially be providing a team of over 80 personnel to the facility including emergency physicians, surgeons, anaesthetists, nurses, midwives, neonatal specialists, obstetricians and paramedics. In addition to the clinical team, Aspen Medical will be providing management, logistics, security, administration and operations specialists to the field hospital.  The Aspen Medical team will work alongside 48 national health personnel of different cadres already recruited to support trauma care at the hospital.  Glenn Keys, Co-Executive Chairman and co-founder of Aspen Medical, said, “ISIL completely destroyed the healthcare infrastructure and now the world has an opportunity to help the long-suffering civilians of Mosul.  Working in partnership with other national and international organisations in the region, our collective challenge is to ensure access and availability of a high quality of medical care for those fleeing Western Mosul.” Dr Andrew Walker, Co-Executive Chairman and co-founder of Aspen Medical, said, “This won’t be a job for the faint-hearted.  We are honoured to be a critical part of this international humanitarian response and we look forward to working closely with WHO and the Ninewa Directorate of Health in Iraq.” With the commencement of the offensive in Mosul, there is likely to be a significant increase in trauma casualties.  Mosul is a city of about 1.2 million people and casualties have been high.  Nearly half the casualties are civilians and this includes a high proportion of children. Aspen Medical is no stranger to pulling together challenging healthcare projects at short notice around Australia and the world.  The company was one of the only organisations in the world to be contracted by four separate countries to deliver their Ebola response.  The company was initially engaged to establish and manage four Ebola Treatment Units in Liberia on behalf of the US Government.  Aspen Medical also established and ran the Australian and New Zealand Governments’ Ebola Treatment Centre in Sierra Leone from mid-December 2014 until the end of April 2015.  Aspen Medical continued to play a crucial role in Sierra Leone where it managed the Kerry Town Treatment Unit on behalf of the UK Government as well as providing support to the laboratory run by Public Health England until the end of November 2015.  In November 2016, Aspen Medical won the International Project Management Association gold medal in the Overseas Humanitarian Aid category for its Ebola Response work in West Africa. Aspen Medical has also delivered challenging and critical projects in the area of Indigenous health across Australia and supports numerous governments in key projects worldwide, from Australia to the UK, the USA, Africa and the Middle East.  Health professionals interested in roles at the Aspen Medical field hospital in Mosul should visit the company’s website at www.aspenmedical.com/recruitment. ENDS For further enquiries please contact:Marketing and Communications Director M  +61 (0)408768791    E    marketing@aspenmedical.com.au Are we travelling in right direction to cure our diseases? 2017-03-24T06:33:10Z are-we-travelling-in-right-direction-to-cure-our-diseases There are many medicines and advancements in treating diseases, but are we cured completely? I have a friend who suffered from severe tonsillitis. He had a surgery after which he faced endless pneumonias and bronchitis. Removing the protective barrier (tonsil tissue) has enabled a free-flow of germs and caused more inward infections. So what is the right cure?  A healing process should proceed from center to circumference says Homeopathic theory. When there is a skin disease,  suppression of the itching and rashes happens with conventional medicine and we are happy about it. But, the disease energy travels inward and gives rise to many other problems.  Confused? Alternative medicine and therapies come to our rescue here. Dr. Sajimon George is a devotee of Nature's healing powers. He is an Ayurvedic Practitioner and Director of one of the successful alternative clinics in Melbourne, Australia -  Ayurclinic. He operates with ten different practitioners in Ayurveda, Homeopathy and Yoga. His association with Ayurveda began from his childhood and has firmly established the power of natural healing with the people of Australia.  Foxtel and Business View Oceania has recently featured his hard work and success. His passion towards natural healing has enabled him to gain the trust of many clients .  Finally it is worth a try for us all to believe in Nature. Global Medical Imaging Market To Grow At A CAGR Of 4.95% During The Period 2017-2021 2017-03-23T11:59:08Z global-medical-imaging-market-to-grow-at-a-cagr-of-4-95-during-the-period-2017-2021 Body for Clinical Analysis And Medical Intervention. Medical Imaging is performed to reveal the internal structures hidden by the skin and bones to examine and diagnose the medical condition. It plays a vital role not only in diagnosis but also in the treatment process as it is taken into consideration during the follow-up of various diseases. Various methods for medical imaging include X-rays, SPECT/PET, ultrasound, CT, and MRI. For the diagnosis and treatment of various diseases, these methods are used individually or in combination for a better understanding of the medical condition. Analysts forecast the Global Medical Imaging Market To Grow At A CAGR Of 4.95% During The Period 2017-2021. Browse Full Report with TOC: http://www.orbisresearch.com/reports/index/global-medical-imaging-market-2017-2021 Covered in this report The report covers the present scenario and the growth prospects of the global medical imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of medical imaging equipment by product type such as: ·         MRI ·         CT Scanners. ·         X-rays ·         Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) ·         Ultrasound The market is divided into the following segments based on geography: ·         Americas ·         APAC ·         EMEA Global Medical Imaging Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Enquire about Medical Imaging Market@ http://www.orbisresearch.com/contacts/enquiry-before-buying/228485 Key vendors ·         Fujifilm ·         GE Healthcare ·         Hitachi Medical ·         Philips Healthcare ·         Siemens Healthcare ·         Toshiba Medical Systems Other prominent vendors ·         Accuray ·         Accutome ·         Alpinion Medical Systems ·         Analogic Corporation ·         ASAHI Roentgen ·         BenQ Medical Technology ·         Shenzhen Bestman Instrument ·         BMV Technology ·         Boston Scientific ·         Brain Biosciences ·         BrainLab ·         Bruker ·         Capintec ·         Carestream Health ·         Cephasonics ·         Chison ·         CMR Naviscan ·         ContextVision ·         CurveBeam ·         DDD-Diagnostic ·         Delphinus Medical Technologies Market driver ·         Growing government initiatives coupled with funding and partnership with equipment manufacturers Market challenge ·         Growing end-users' preference toward refurbished equipment Market trend ·         Growing demand for portable imaging equipment Key questions answered in this report What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?Table of ContentsPART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by product PART 07: Market segmentation by application PART 08: Market segmentation by end-user PART 09: Market segmentation by size PART 10: Geographical segmentation PART 11: Market drivers PART 12: Impact of drivers PART 13: Market challenges PART 14: Impact of drivers and challenges PART 15: Market trends PART 16: Vendor landscape PART 17: Key vendor analysis PART 18: Appendix List of Exhibits Exhibit 01: Key countries Exhibit 02: Product offerings Exhibit 03: Snapshot of global medical imaging market Exhibit 04: Key buying criteria for medical imaging equipment Exhibit 05: Buying criteria for medical imaging equipment Exhibit 06: Global medical imaging market growth perspectives: Developed and emerging markets Exhibit 07: Global medical imaging market 2017-2021 ($ billions) Exhibit 08: Opportunity analysis of global medical imaging market Exhibit 09: Five forces analysis Exhibit 10: Global medical imaging market by product type 2016 and 2021 (% share) Exhibit 11: Global medical imaging market segmentation by product type 2017-2021 (% share) Exhibit 12: Global general X-ray imaging market 2016-2021 ($ billions) Exhibit 13: Global ultrasound imaging market 2016-2021 ($ billions) Exhibit 14: Global MRI imaging market 2016-2021 ($ billions) Exhibit 15: Global CT Scanner imaging market 2016-2021 ($ billions) About Us:                                                                    Orbis Research is a single point aid for all your Market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required Market research study for our clients. Contact Us:Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817; +912064101019 Email ID: sales@orbisresearch.com Advances in Digital Agriculture to Take Centre Stage at International Symposium on Digital Earth & Locate17 in Sydney 2017-03-22T22:59:02Z advances-in-digital-agriculture-to-take-centre-stage-at-international-symposium-on-digital-earth-locate17-in-sydney Sydney, Australia – 23 March 2017 – Advances in spatial technology that enable digital agriculture, including a next-generation national positioning system and real-time monitoring of soil moisture levels from space, will take centre stage at the International Symposium on Digital Earth & Locate17 in Sydney in April. A new national positioning system accurate to between 2cm and 10cm – as opposed to 5 metres with today’s satellite-based GPS – will boost Australia’s economy by $73 billion or more over the next 20 years, much of it in agriculture, says Dr Peter Woodgate, CEO of the Cooperative Research Centre for Spatial Information (CRCSI). “To adopt techniques like precision agriculture and controlled traffic farming, farmers need to be able to position equipment and sensors with about 5cm accuracy. The conference will showcase space-based augmentation systems – including Australia and New Zealand’s joint initiative – which, subject to testing, are well on the way to achieving that,” said Woodgate. “Leveraging other regional efforts, such as a Japanese satellite-based system recently trialled in Queensland, it will even be possible to remotely control unmanned autonomous vehicles like driverless tractors from space.” Australia’s investments in positioning systems will not only pay off in higher agricultural exports but will create export business opportunities and new jobs in digital agriculture to aid the transition from sectors of the economy impacted by digital disruption. Woodgate and fellow Working Group Co-Chair, Glenn Cockerton, Managing Director of Spatial Vision, will make the first public presentation of the 2026 Spatial Industry Transformation and Growth Agenda at Digital Earth & Locate17, outlining 30 transformative initiatives for Australia. In another highlight of the event, the U.S. National Aeronautics and Space Administration (NASA) will hold a special session to promote capacity building and use of data from its Soil Moisture Active Passive (SMAP) Observatory. SMAP products, which provide frequent global measurements of soil moisture from space at high spatial resolution, are freely available (http://nsidc.org/data/smap), with one of the first validation experiments carried out in Yanco, NSW. According to Phil Tickle, Program and Business Development Manager (Ag, NRM & Climate Change) at CRCSI, NASA’s SMAP data will complement data from a range of sensors used in digital agriculture, including soil moisture probes, weather stations, and animal tracking devices. Tickle is presenting the benefits of an online farm monitoring solution for the grazing industry at Digital Earth & Locate17. Called the NRM Spatial Hub, this provides access to 30 years of 30 metre resolution satellite data and tools for mapping, assessing and monitoring property infrastructure, land resources and ground cover. It is currently being commercialised by the CRCSI in conjunction with Meat & Livestock Australia. Tickle said the conference was an opportunity for farmers and land managers to learn about the spatial technologies transforming their industry, as well as to discuss potential issues, such as the ownership of agricultural big data. “We are seeing enormous development in digital agriculture capabilities and often farmers don’t have control of their own data,” said Tickle. “When you have sensors on farms feeding into data warehouses and generating broader benefits, why shouldn’t the farmer get a cut? And what does a farmer do if they want to change providers and their data is locked up in a proprietary system?” With a program featuring more than 130 international and Australian speakers, Digital Earth & Locate17 provides a unique opportunity to understand digital transformation practices from around the world, and to develop and leverage geospatial data. The two main conference days will be split into eight separate streams with topics including smart cities, virtual globes, intelligent transport, agriculture, engineering/utilities, smart sensors for natural resource management, water & climate, disaster & emergency management, and the geospatial economy. The joint conference will be held 03-06 April 2017 at the new International Conference Centre Sydney. The Digital Earth & Locate17 Conference’s Market Day on Tuesday 4th April opens the exhibition to everyone and is an opportunity for private, government and start-up organisations to come together and explore collaborative and business opportunities. About the International Symposium on Digital Earth The International Symposium on Digital Earth is a flagship event of the International Society for Digital Earth. Founded in Beijing in 2006, ISDE is a non-political, non-governmental and not-for-profit international organisation principally promoting academic exchange, science and technology innovation, education, and international collaboration towards Digital Earth. ISDE also explores Digital Earth as an enabling technology to play key roles in economic and social sustainable development, environmental protection, disaster mitigation, natural resources conservation and improvement of living standards. About Locate17 The Locate Conference (Locate17) is the national conference of the spatial and surveying industries of Australia and New Zealand. The event is an initiative of the Surveying & Spatial Sciences Institute (SSSI), Spatial Industries Business Association (SIBA) and Geospatial Information & Technology Association (GITA). PromarkerD Predictive Diagnostics for DKD to Roll-out in Asia 2017-03-22T16:23:09Z promarkerd-predictive-diagnostics-for-dkd-to-roll-out-in-asia PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader in biomarker discovery in multiple project areas, is advancing deals this week in Singapore, Hong Kong and Shanghai for the Asia Pacific commercialization of PromarkerD, the ground-breaking test platform that uses protein biomarkers in the blood to predict the onset of diabetic kidney disease (DKD). Proteomics, or PILL, has been granted patents for PromarkerD in China and Singapore, following grants in Australia, Russia and the USA.There are currently no available tests for predicting the onset of diabetic kidney disease (DKD). 400 million people worldwide are living with diabetes, of which 231 million are in Asia alone, according to the International Diabetes Federation, with DKD ultimately affecting approximately one-third of all adult diabetics. Patients on dialysis can incur costs of $100,000 a year, while the global diabetes epidemic cost health systems more than $673 billion in 2015."Early detection is the key to saving lives and saving money, as patients may take lifestyle and medication action immediately to cut their risks," says Dr Richard Lipscombe, Managing Director of PILL. "PromarkerD means we can accurately predict if someone will acquire kidney disease within 4 years. Clinical results have shown that PromarkerD can predict 95% of those diabetic patients who will go on to develop chronic kidney disease."PromarkerD technology was recently validated by the peer-reviewed journal EuPA Open Proteomics(1), the official journal of the European Proteomics Association (EuPA), while a new independent report by Frost & Sullivan, BIOMARKERS IN DIABETES AND OBESITY MANAGEMENT(2), recognizes PILL as a leader in the field and highlights the role that, "PromarkerD, and the early diagnosis of DKD, can play across the Asia-Pacific region."(2) "Biomarker technologies that are likely to aid in the effective management of obesity, diabetes, and related complications are likely to have a high adoption potential across the Asia Pacific landscape," the Frost & Sullivan analysts say, "as Japan, China, Singapore, and India have a high prevalence of diabetes.""If we can stem this health crisis tsunami by identifying and treating people before they become symptomatic, we are saving lives as well as billions of dollars in health costs," said Dr Lipscombe. (1) "Comprehensive Mass Spectrometry Based Biomarker Discovery and Validation Platform as Applied to Diabetic Kidney Disease", EuPA Open Proteomics 14(C): 1-10, January 2017.(2) "Biomarkers Enabling Diabetes and Obesity Management", Frost & Sullivan, D7A6-01, March 2017. Promarker PlatformPILL's diagnostic research is part of the company's proprietary biomarker discovery platform termed Promarker, which searches for protein 'fingerprints' in a sample. This disruptive technology can identify proteins that distinguish between people who have a disease and people who do not, using only a simple blood test. It is a powerful alternative to genetic testing.The technology is so versatile it can be used to identify fingerprints from any biological source. The Promarker platform is also being applied to the asbestos-related cancer mesothelioma, the gastro-causing parasite Giardia (in partnership with a US veterinary company), and endometriosis, a condition that affects one in ten women in their reproductive years.PromarkerD Diagnostic Test for Diabetic Kidney DiseaseThe test can both diagnose and predict diabetic kidney disease. In diabetic patients already suffering from chronic kidney disease, PromarkerD successfully diagnosed the presence of disease missed by current gold standard tests (known as the ACR and eGFR tests). Critically, PromarkerD can also predict the onset of disease before clinical symptoms appear. In an extension of the published work, 576 patients were followed in a four year longitudinal clinical study. PromarkerD accurately predicted 95% of the previously kidney disease-free diabetic patients who went on to develop chronic kidney disease. About Proteomics International Laboratories Ltd (PILL)PILL (ASX: PIQ) is a medical technology company focused on proteomics - the industrial scale study of the structure and function of proteins. Proteins recently became the drug class of choice for the pharmaceutical industry because of their intimate role in biological systems, as proteomics technology is now playing a key role in understanding disease, from identifying new diagnostic biomarkers to determining drug targets, and discovering new biopharmaceutical drugs.PILL is recognised as a global leader in the field of proteomics, receiving the world's first ISO 17025 laboratory accreditation for proteomics services. The Company operates a proprietary technology platform across three integrated areas: Diagnostics, Analytical Services, and Drug Discovery. PILL is located in state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth, Western Australia. To learn more, please visit www.proteomics.com.au.Contact:Dr Richard Lipscombe Managing Director, Proteomics International Laboratories Ltd E: enquiries@proteomics.com.au T: +61 2 8218 2144 Media Contact: Susan Fitzpatrick-Napier Digital Mantra Group T: +61 8 9389 1992 E: team@dmgpr.com Comfort-in™ – A Versatile Needle-free Injection System for Everybody 2017-03-22T06:22:04Z comfort-in-a-versatile-needle-free-injection-system-for-everybody What is the Comfort-in™? The Comfort-in™ is an easy to use, virtually pain-free, needle-free jet injector system, which eliminates the fear, pain, and danger of needles from the injection process. We believe it’s the most versatile injector on the market because it can be used by both professionals and patients at home for almost anything you would normally use a needle to inject. Common uses include insulin injections, use in dental clinics, vitamin injections such as methyl B12, with suffering from erectile dysfunction (ed), hormone therapy, growth hormones, IVF treatments, allergy shots, and so much more. As much as 25% of adults and up to 75% of children have needle-phobia. This contributes to situations where adult patients delay or forego treatment altogether, and physicians and other professionals such as dentists, are left in an awkward position of having to cause pain. Parents are left with the tough decision of causing their child pain, or not getting the proper medical care. Do you want an alternative to needle-based syringes – a more comfortable and calm solution for injecting medicine and supplements? The Comfort-in™ is your solution to a virtually painless injection rather than having to endure the fear and anticipation and pain of a needle. Economic and Environmental Impact The Comfort-in™ can be used for up to 10,000 injections – which makes it the longest lasting reusable needle-free injector that we know of in the market, while other devices are limited to as little as 1,000. The longer use life of the Comfort-in™ means less waste ending up in landfills, and lower overall cost for the consumer. Also, unlike needles, there are no special disposal requirements, so it could be broken down. Also, we do not use any gases or liquid propellants like. How do I get this revolutionary device? The Comfort-in™ needle-free injection system is available to the general public and to professionals around the world, for purchase online at https://www.injectneedlefree.com. You can also find them in pharmacies throughout Australia. The Comfort-in™ starter kit contains everything necessary to get started. Additional disposable components (such as syringes and adapters) can be purchased from pharmacies or online at https://www.injectneedlefree.com. How do I use Comfort-in™? You can visit https://www.injectneedlefree.com/instructions/ for detailed instructions including videos. Every kit comes with an instruction manual, and additional manuals are available in other languages on our website.Some of the pharmacies in Australia also demonstrate the use for customers. Some of the pharmacies in Australia who carry the Comfort-in™ also demonstrate the use for customers. How does Comfort-in™ work? Liquid medications are transferred into the needle-free nozzle/syringe via adapters. There are 5 different adapters available to suit all types of injectable liquid from any type of pen, vial or cartridge. The needle-free nozzle/syringe can contain up to 0.5ml per single injection. After loading the injector, the liquid medication in the nozzle/syringe is propelled effortlessly as a small jet into the body via a spring-action. The liquid medication disperses into the subcutaneous tissue via the path of least resistance, in a cone-like shape. There are no sharp needles penetrating through delicate skin and tissue. This reduces the likelihood of tissue damage, the formation of scar tissue and the chance of developing lipohypertrophy (lumps under the skin caused by multiple injections in the same area of skin over an extended period of time or re-using the same needle without correct sterilisation). This is a common issue for sufferers of Type 1 Diabetes. The Comfort-in™ needle-free injection is fast, safe, quickly absorbed by the body and ‘virtually’ painless.   Who is Comfort-in™ Australia? Needle-phobia and the discomfort of ongoing needle injections is a real barrier for many people who require ongoing medical care. Comfort-in™ is here for those people, whatever their needs may be. We are committed to providing reliable needle-less injection technology to both professionals and private users alike and we aren’t going anywhere!Those who are familiar with needle-free technology will be aware that in the last two decades, a number of companies around the world declared an interest in developing ‘needle-free’ injector systems. What has happened to them? Some went bankrupt and some couldn’t keep up with supply demands. One sold their jet injector technology to a massive syringe and needle manufacturer who put it on a back shelf, another to a pharmaceutical company requiring a prescription and limited use and availability. We are proud to stand by our commitment to continue to provide the Comfort-in™ to the general public as well as professionals. We have no intention of selling to syringe or needle companies, or pharmaceutical companies that would restrict your access to this revolutionary product. Learn more at https://www.injectneedlefree.com 80 heads shaved in 80 minutes! 2017-03-16T23:05:28Z 80-heads-shaved-in-80-minutes Media Alert: Sydney Australia - Friday 17 March WHAT: Today, a record number of St. Augustine’s College Brookvale schoolboys will shave their heads and raise money to help fellow 13 year old student, Liam Donohoe, beat leukaemia. Sadly, Liam was diagnosed with Pre-B ALL (Acute Lymphoblastic Leukaemia) in December 2016 and since has been receiving intense treatment at Sydney Children’s Hospital, Randwick with his parents Brendan and Nicole at his side. This extraordinary effort by the St Augustine boys was inspired by 5 core friends of Liam’s who “just wanted to do something for their mate”. The school boys will be joined today by teachers, staff members and local barbers and hairdressers to all come together for Liam.  So far, close to $35,000 has already been raised, which is well on the way to reaching the goal of $50,000.  WHERE: Augustine's College Brookvale - Federal Parade, Brookvale NSW 2100 WHEN: TODAY, March 17 at 1pm WHY: “Every day, 35 Australians will be given the devastating news that they have leukaemia, lymphoma or myeloma, and they’ll turn to the Leukaemia Foundation for help,” said Monique Cerreto at the Leukaemia Foundation of Australia. The Leukaemia Foundation receives no ongoing government funding and the World’s Greatest Shave helps fund urgent life-saving research and gives families the emotional and practical support they need, free of charge. “When you’re healthy, it’s hard to understand the value of counselling, transport to and from chemotherapy, or being given a place to stay free of charge during treatment if you come from outside city suburbs. But this support matters when you’re too sick to work, and financial and emotional stress levels are high,” Monique said.  For more information www.worldsgreatestshave.com  or by calling 1800 500 088. ABOUT: About the Leukaemia Foundation. The Leukaemia Foundation the only national charity dedicated to improving the lives of patients with all types of blood cancers including leukaemia, lymphoma and myeloma. We want more people to survive a blood cancer diagnosis and go on to live a full life. We are committed to investing in research projects which focus on improving patient outcomes and providing free support programs which aim to reduce the emotional impact of a blood cancer diagnosis.  For more information please visit http://www.leukaemia.org.au/or visit Facebook, Twitter or Youtube. Aussies get set for a hairy challenge 2017-03-14T22:38:16Z aussies-get-set-for-a-hairy-challenge-1 SYDNEY, Australia: March 15 2017: Today, The Leukaemia Foundation will be at the Martin Place Amphitheatre to kick off the World’s Greatest Shave with special guests including Waratah’s captain Michael Hooper and other players including Matt Lucas.  Sydneysiders are being asked to accept the hairy challenge of getting sponsored to shave, cut, wax or colour their hair to help raise needed funds for residents in NSW fighting blood cancer. “Every day, 35 Australians will be given the devastating news that they have leukaemia, lymphoma or myeloma, and they’ll turn to the Leukaemia Foundation for help,” said Monique Cerreto at the Leukaemia Foundation of Australia. “Getting sponsored to shave your hair is an extraordinary way to support them. The Foundation receives no ongoing government funding and the World’s Greatest Shave helps us fund urgent life-saving research and gives families the emotional and practical support they need, free of charge. “When you’re healthy, it’s hard to understand the value of counselling, transport to and from chemotherapy, or being given a free place to stay during treatment if you come from outside city suburbs. But this support matters when you’re too sick to work, and financial and emotional stress levels are high,” she said. World’s Greatest Shave is accessible to people of all ages and you don’t have to shave your head to join this iconic Australian event.  “More than 150,000 people are expected to take part in World’s Greatest Shave from March 16-19 and they’ll do so at home, work, school and our public events,” Monique said. “Shaving is what we’d love everyone to do, but people can colour their hair instead and guys can wax their legs or chest. We’re also asking men who are thinking about ditching their hipster beard or mo, to make the change while supporting a worthy cause.” Whether motivated by a personal connection or the desire to help others, people who shave also help to normalise baldness, one of the most distressing side-effects of cancer treatment. “Shavers get to feel empathy with people who don’t get a choice to lose their hair. This is often described as an unexpected but powerfully life-changing experience by women. Sign up now at worldsgreatestshave.com or by calling 1800 500 088. --ENDS-- About the Leukaemia Foundation  The Leukaemia Foundation the only national charity dedicated to improving the lives of patients with all types of blood cancers including leukaemia, lymphoma and myeloma. We want more people to survive a blood cancer diagnosis and go on to live a full life. We are committed to investing in research projects which focus on improving patient outcomes and providing free support programs which aim to reduce the emotional impact of a blood cancer diagnosis. For more information please visit http://www.leukaemia.org.au/or visit Facebook, Twitter or Youtube. Spatial Startup Companies to Share the Latest Innovations at the International Symposium on Digital Earth & Locate17 2017-03-14T00:00:19Z spatial-startup-companies-to-share-the-latest-innovations-at-the-international-symposium-on-digital-earth-locate17 Sydney, Australia – 14 March 2017 – Virtual reality, drones and multi-Global Navigation Satellite Systems are among the innovations to be showcased in the Startup Hub at the International Symposium on Digital Earth & Locate17, taking place from 3-6 April 2017 at the new International Conference Centre Sydney. The Startup Hub is designed to bring innovators and providers of the latest spatial technologies to the attention of scientists, surveyors, businesses and government. It will be located in the exhibition hall throughout the conference, including the free Market Day on Tuesday 4th April. All exhibition visitors are invited to try out the new technologies and the new opportunities they provide. Virtual reality to reimagine the world Forum8 is demonstrating its custom 3D visualisation and virtual reality (VR) software. Complete with an Oculus VR headset, the demonstration will showcase the future of 3D experiences. Forum8’s VR-Design Studio is specifically focused on 3D VR/visualisation of urban spaces, roads and traffic, and rail. It provides a full environment for visualising a concept, including Australian terrain (DEM) and road design-type tools, vehicles and traffic settings. It is also possible to import data from a range of sources, including point cloud, road design tools and traffic simulations. The software is also used with driving simulators in engineering studies and human factors research. Rapid-fire spatial data capture Spatial Technologies Pty Ltd will showcase ground breaking technologies that are the results of research and development completed in 2016. This includes new and existing technologies like 3D laser scanning, unmanned aerial vehicle (UAV) point clouds and light sensors. A number of projects utilising a combination of these will be showcased, including rapid tree inspections, street light management and asset management. Multi-satellite solutions SURVEY SOLUTIONS will use the Startup Hub for its Australian launch following successful sales of its SOUTH GNSS multi-Global Navigation Satellite Systems receiver in New Zealand. The receiver uses the latest GNSS boards to receive the full constellation of satellites available, weighs less than 1kg and is affordably priced compared with competing products. Giving meaning to spatial data Professional spatial problem solvers, Anditi, will also be on hand to show how spatial analytics can solve everything from energy sources to safety. The company is showcasing its next generation platform for high-precision spatial analytics and its application in a range of industries such as solar, property, roads and infrastructure, mining, and environment. It has been designed and built in Australia to revolutionise the management, processing and visualisation of spatial big data such as high-resolution LiDAR. Anditi will also be highlighting use cases across natural and built environments where its application is benefiting clients with lower costs and higher quality outcomes. The Startup Hub will be held in the exhibition halls of the Digital Earth & Locate17 Conference from 3-6 April 2017 at the new International Conference Centre Sydney. With a program featuring more than 130 international and Australian speakers, the event provides a unique opportunity to understand digital transformation practices from around the world, and to develop and leverage geospatial data. The two main conference days will be split into eight separate streams with topics including smart cities, virtual globes, intelligent transport, agriculture, engineering/utilities, smart sensors for natural resource management, water & climate, disaster & emergency management, and the geospatial economy. About the International Symposium on Digital Earth The International Symposium on Digital Earth is a flagship event of the International Society for Digital Earth. Founded in Beijing in 2006, ISDE is a non-political, non-governmental and not-for-profit international organisation principally promoting academic exchange, science and technology innovation, education, and international collaboration towards Digital Earth. ISDE also explores Digital Earth as an enabling technology to play key roles in economic and social sustainable development, environmental protection, disaster mitigation, natural resources conservation and improvement of living standards. About Locate17 The Locate Conference (Locate17) is the national conference of the spatial and surveying industries of Australia and New Zealand. The event is an initiative of the Surveying & Spatial Sciences Institute (SSSI), Spatial Industries Business Association (SIBA) and Geospatial Information & Technology Association (GITA). The Hidden Health Crisis Killing Australians 2017-03-13T01:07:55Z the-hidden-health-crisis-killing-australians-1 A record number of Australians are accidentally overdosing on prescription medicines in what medical authorities have labelled ‘an opioid epidemic’. According to the Australian Bureau of Statistics, the number of deaths from prescription painkillers - opioids - has increased 61 percent between 2004-2014. Further key facts and figures are showing no stopping this hidden health crisis. However, the real question is, why is this happening? Medical authorities such as Australia’s Penington Institute note that the deaths caused from opioid overprescription between 2008-2014 underscores how severe the overdose crisis is in Australia. 69 percent of all drug-related deaths in Australia come from prescription painkillers. Additionally, 58 percent of non-cancer opioid prescriptions are for musculoskeletal issues, commonly including back pain and neck pain.   To bring more attention to this public health issue, Sydney based Chiropractor Doctor Rosemarie Jabbour (Chiropractor) is raising awareness of The Penington Institute’s findings and is looking for different options to help those people who suffer from pain caused by musculoskeletal issues.   “Prevention is better than cure, we all know that. However, when it comes to our spine, chiropractic is found to be a good form of care for back and neck pain. In many cases, chiropractors aim to address the underlying cause of pain,” Doctor Jabbour (Chiropractor) said.   The medical compound in question - opioids - are one of the most commonly prescribed drug classes for pain. Alarmingly, the efficacy of long-term opioid use has been called into question. An Experimental and Clinical Psychopharmacology Review highlighted the uncertainly about the appropriate role of these drugs in the treatment of pain, and that the long-term administration of opioids for the treatment of chronic non-cancer pain continues to be controversial.   “That is why chiropractic is the more natural and logical choice. It is a drug-free alternative. Hence the side effects you could otherwise get from these painkillers are avoided,” Doctor Jabbour (Chiropractor) said.   Although the increase in opioid overdose and accidental death is an urgent issue to be addressed, there is also growing awareness that other forms of treatment, including manual therapies such as chiropractic, have a role to play in aiming to address pain caused by musculoskeletal issues.   “We see many patients who have been on this opioid merry-go-round for a long time and it’s quite difficult for them to break the cycle of addiction. For some patients, the benefits received through chiropractic care and the rehabilitation we offer in many cases outweighs the long term taking of these drugs,” Doctor Jabbour (Chiropractor) said.   All forms of healing have their place, but when research shows an increase in troublesome addiction and overdose, perhaps we need to rethink our approach to pain management. In the first instance, natural and lower risk treatment options, such as chiropractic, may be considered in some cases. If you think you may have a dependence on painkillers or are looking for natural treatment options, why not phone your local chiropractor and ask about the services they offer. Dr. Rosemarie Jabbour (Chiropractor) New World Chiro (02) 9687 4011 rosemarie@newworldchiro.com.au http://www.newworldchiro.com.au DNA Sampling for the dead 2017-03-12T21:54:04Z dna-sampling-for-the-dead A leading Sydney based funeral company has recently introduced for the first time in Australia, DNA sampling for the dead. The idea started, when stories emerged about family history of medical conditions, namely generations dying of the same disease. The spokesperson for the funeral company says: " never before has there been a better opportunity to collect this information, especially for families who have a history of complaints or diseases. We believe we can help people to better understand this, by taking a sample of the body before burial or cremation". The simple practice of a funeral has changed over the years,  creating  more options for families at their time of need can only be a benefit to society. The Genetic Testing Laboratories Expands Portfolio of Clinical Tests 2017-03-08T10:36:31Z the-genetic-testing-laboratories-expands-portfolio-of-clinical-tests Springwood- Queensland – 08/03/17 -Australia based genetic testing company The Genetic Testing Laboratories (also known as GTL Australia) has launched a new range of clinical DNA tests to its existing portfolio in partnership with a leading genetic laboratory in Australia. The company has recently introduced a blood based Allergy test, which analyses various allergy panels and measures the levels of the allergy antibody IgE in response to the allergens tested. GTL Australia has also launched Pharmacogenomic testing, a cutting edge-test which tests an individual’s gene response to certain drug classes as well as an Inherited Disease Panel which covers a person’s genetic predisposition to over 700 diseases. The latest addition to the portfolio is the Post Natal Test which establishes a baby’s risk for 50 inherited disorders and includes information regarding the baby’s ability of metabolizes 20 different drugs. Commenting on this significant venture, GTL’s sales and marketing manager states that “we believe clinical testing and personalized medicine are what medicine and health care is moving towards. The gradual paradigm shift is becoming more obvious with the growing requests we get not only from individuals, but also from doctors and clinics who wish to better advise, treat, prevent and guide their patients through access to various clinical tests such as gluten testing or pharmacogenomic testing.” The Genetic Testing Laboratories notes that is only offers its portfolio of tests following Australian guidelines “the tests must be ordered by a doctor and results sent to doctor. The client can then discuss their results with the doctor. With an ever-growing demand for patient satisfaction, effective treatments and positive outcomes, the company foresees an evolution in the field of clinical tests which will become an integral part of detecting, managing and preventing diseases and illnesses. The company also notes how it is not only the private medical and health sector that can benefit from these tests but public hospitals and other state run health care entities which should seek collaborations with private companies and laboratories that offer these tests because “clinical tests can potentially save millions of dollars and reduce pressure on the public health service which is already under strain in many countries. Having access to such targeted treatments, based on the results of genetic testing, can avoid use of ineffective drugs, over or under prescribing, which amongst many other related issues, just increase the tab on public health care spending” About GTL The Genetic Testing Laboratories offers health, clinical relationship as well as parentage testing services. It is one of the leading companies in Australia, with offices in countries including the United Kingdom. First Australian Toxicologist to become President Elect of International Union of Toxicology (IUTOX) 2017-03-07T04:28:18Z first-australian-toxicologist-to-become-president-elect-of-international-union-of-toxicology-iutox Melbourne Australia (3 March 2017) Dr Di Marco served on the IUTOX Executive Committee for two terms from 1996 to 2001 as chair of the Commission on Developing Countries and Countries in Economic Transition. IUTOX is an organisation that aims to increase awareness of toxicological issues facing humankind across the globe. Founded in 1980, IUTOX has established itself as the voice of toxicology on the global stage with 63 affiliated societies with a collective membership base of over 25,000 members across six continents: Africa, Asia, Australia, Europe, North and South America.    Dr Di Marco will also serve as Chair of the IUTOX Scientific Committee, which co-chairs national and international scientific programme committees for IUTOX associated scientific activities and congresses. He has a strong interest in facilitating the growth of the science of toxicology in developing countries as well as countries in economic transition.  Dr Peter Di Marco will serve as President Elect for three years and will become President of IUTOX in 2019. Dr Di Marco believes his role as ACTRA President for the last four years, Vice President for the previous six; as well as his previous experience on the IUTOX Executive committee; has given him the knowledge and experience to successfully take on the role. Dr Di Marco believes his role will help promote the importance of unifying Toxicologists and Risk Assessors here in Australasia. “ACTRA was established in 2006 with the aim of providing a professional scientific organisation to support persons engaged in the sciences of toxicology and health risk assessment in Australasia” Di Marco said. “An important objective in establishing ACTRA was to initiate a process whereby the professional standing and credentials of Australian and New Zealand toxicologists and health risk assessors (HRAs) could receive some type of formal, peer-reviewed recognition.” “As ACTRA President I am honoured to have been elected to lead IUTOX and look forward to continue the great work done by IUTOX since 1980 in bringing toxicology to the world for the betterment of humankind.  I am also pleased that I am in a better position to raise the profile of ACTRA in Australasia and internationally.” ACTRA advances the study and applications of toxicology and health risk assessment as professional scientific disciplines, and cultivates the highest standards of professional practice and ethics in persons engaged in the sciences of toxicology and health risk assessment in Australasia. To learn more about ACTRA visit www.actra.org.au Australasian College of Toxicology and Risk Assessment Suite 5, 250 Gore Street,  Fitzroy VIC 3065